32 / 60
32
Scientific programme
Saturday, 30 May 2015
HT-12
Hot Topic Symposium
14:30–16:00
Alsh 1/2
Early life factors as origin of ADHD
Chairs:
B. van den Bergh, The Netherlands
C. Tiesler, Germany
HT-12-001 Prenatal maternal anxiety and ADHD-
related behaviour and cognitive task
performance in the adolescent offspring
B. van den Bergh, The Netherlands
HT-12-002 Perinatal exposure to nicotine and tobacco
smoke in relation to the onset of ADHD
C. Tiesler, Germany
HT-12-003 Maternal alcohol consumption during
pregnancy and childhood hyperactivity/
inattention
K. Sayal, United Kingdom
HT-12-004 Perinatal exposure to persistent organic
pollutants and metals and ADHD
T. I. Halldórsson, Iceland
HT-13
Hot Topic Symposium
14:30–16:00
Carron 1/2
Neurobiological mechanisms underlying drug
treatment in ADHD
Chairs:
U. Müller, United Kingdom
J. Newcorn, USA
HT-13-001 The effects of stimulant and non-stimulant
medication on the ADHD brain
K. Rubia, United Kingdom
HT-13-002 Nigro-striatal mechanisms underlying
ADHD and its treatment with methyl-
phenidate
U. Müller, United Kingdom
HT-13-003 Dopamine transporter genotype and
dose-response following treatment
with psychostimulants: Implications for
optimization of acute and longer-term
treatment
J. Newcorn, USA
HT-14
Hot Topic Symposium
14:30–16:00
Dochart 1/2
Unstable wakefulness regulation: A common patho
genetic factor in ADHD and manier
Chairs:
U. Hegerl, Germany
M. Romanos, Germany
HT-14-001 The noradrenergic neurotransmitter sys-
tem in ADHD
T. Vanicek, Austria
HT-14-002 Vigilance regulation in adult ADHD
M. Strauß, Germany
HT-14-003 Results of the international multicentre,
iSPOT-A study in ADHD: EEG predictors of
treatment outcome to methylphenidate
M. Arns, The Netherlands
HT-14-004 The effects of stimulant medication on
vigilance regulation in childhood ADHD
J. Geissler, Germany
HT-15
Hot Topic Symposium
14:30–16:00
Boisdale 1
Dopaminergic motor behavioural and behavioural
motor disorders
Chairs:
P. Riederer, Germany
E. Wolters, The Netherlands
HT-15-001 Iron deficiency, sleep disturbances, dopa-
mine and ADHD
M. Youdim, Israel
HT-15-002 ADHD altered dopamine neurotrans-
mission and disrupted reinforcement
processes: Implications for smoking and
nicotine dependence
S. H. Kollins, USA
HT-15-003 Dopamine dysregulation syndrome, and
impulse control disturbances
E. Wolters, The Netherlands
HT-15-004 Dopamine dysfunctions in motor abnor-
malities linked to neurological diseases
and psychiatric disorders
P. Riederer, Germany